MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis.
Despite the importance of microRNAs (miRs) for regulation of the delicate balance between cell proliferation and death, evidence for their specific involvement during death receptor (DR)-mediated apoptosis is scarce. Transfection with miR-133b rendered resistant HeLa cells sensitive to tumor necrosi...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/68eeae15a69047a5905ae63710d8d6e6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:68eeae15a69047a5905ae63710d8d6e6 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:68eeae15a69047a5905ae63710d8d6e62021-11-18T07:21:32ZMiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis.1932-620310.1371/journal.pone.0035345https://doaj.org/article/68eeae15a69047a5905ae63710d8d6e62012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22532850/?tool=EBIhttps://doaj.org/toc/1932-6203Despite the importance of microRNAs (miRs) for regulation of the delicate balance between cell proliferation and death, evidence for their specific involvement during death receptor (DR)-mediated apoptosis is scarce. Transfection with miR-133b rendered resistant HeLa cells sensitive to tumor necrosis factor-alpha (TNFα)-induced cell death. Similarly, miR-133b caused exacerbated proapoptotic responses to TNF-related apoptosis-inducing ligand (TRAIL) or an activating antibody to Fas/CD95. Comprehensive analysis, encompassing global RNA or protein expression profiling performed by microarray experiments and pulsed stable isotope labeling with amino acids in cell culture (pSILAC), led to the discovery of the antiapoptotic protein Fas apoptosis inhibitory molecule (FAIM) as immediate miR-133b target. Moreover, miR-133b impaired the expression of the detoxifying protein glutathione-S-transferase pi (GSTP1). Expression of miR-133b in tumor specimens of prostate cancer patients was significantly downregulated in 75% of the cases, when compared with matched healthy tissue. Furthermore, introduction of synthetic miR-133b into an ex-vivo model of prostate cancer resulted in impaired proliferation and cellular metabolic activity. PC3 cells were also sensitized to apoptotic stimuli after transfection with miR-133b similar to HeLa cells. These data reveal the ability of a single miR to influence major apoptosis pathways, suggesting an essential role for this molecule during cellular transformation, tumorigenesis and tissue homeostasis.Juan P PatronAnnika FendlerMatthias BildUlrike JungHenrik MüllerMagnus Ø ArntzenChloe PisoCarsten StephanBernd ThiedeHans-Joachim MollenkopfKlaus JungStefan H E KaufmannJörg SchreiberPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 4, p e35345 (2012) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Juan P Patron Annika Fendler Matthias Bild Ulrike Jung Henrik Müller Magnus Ø Arntzen Chloe Piso Carsten Stephan Bernd Thiede Hans-Joachim Mollenkopf Klaus Jung Stefan H E Kaufmann Jörg Schreiber MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis. |
description |
Despite the importance of microRNAs (miRs) for regulation of the delicate balance between cell proliferation and death, evidence for their specific involvement during death receptor (DR)-mediated apoptosis is scarce. Transfection with miR-133b rendered resistant HeLa cells sensitive to tumor necrosis factor-alpha (TNFα)-induced cell death. Similarly, miR-133b caused exacerbated proapoptotic responses to TNF-related apoptosis-inducing ligand (TRAIL) or an activating antibody to Fas/CD95. Comprehensive analysis, encompassing global RNA or protein expression profiling performed by microarray experiments and pulsed stable isotope labeling with amino acids in cell culture (pSILAC), led to the discovery of the antiapoptotic protein Fas apoptosis inhibitory molecule (FAIM) as immediate miR-133b target. Moreover, miR-133b impaired the expression of the detoxifying protein glutathione-S-transferase pi (GSTP1). Expression of miR-133b in tumor specimens of prostate cancer patients was significantly downregulated in 75% of the cases, when compared with matched healthy tissue. Furthermore, introduction of synthetic miR-133b into an ex-vivo model of prostate cancer resulted in impaired proliferation and cellular metabolic activity. PC3 cells were also sensitized to apoptotic stimuli after transfection with miR-133b similar to HeLa cells. These data reveal the ability of a single miR to influence major apoptosis pathways, suggesting an essential role for this molecule during cellular transformation, tumorigenesis and tissue homeostasis. |
format |
article |
author |
Juan P Patron Annika Fendler Matthias Bild Ulrike Jung Henrik Müller Magnus Ø Arntzen Chloe Piso Carsten Stephan Bernd Thiede Hans-Joachim Mollenkopf Klaus Jung Stefan H E Kaufmann Jörg Schreiber |
author_facet |
Juan P Patron Annika Fendler Matthias Bild Ulrike Jung Henrik Müller Magnus Ø Arntzen Chloe Piso Carsten Stephan Bernd Thiede Hans-Joachim Mollenkopf Klaus Jung Stefan H E Kaufmann Jörg Schreiber |
author_sort |
Juan P Patron |
title |
MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis. |
title_short |
MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis. |
title_full |
MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis. |
title_fullStr |
MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis. |
title_full_unstemmed |
MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis. |
title_sort |
mir-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2012 |
url |
https://doaj.org/article/68eeae15a69047a5905ae63710d8d6e6 |
work_keys_str_mv |
AT juanppatron mir133btargetsantiapoptoticgenesandenhancesdeathreceptorinducedapoptosis AT annikafendler mir133btargetsantiapoptoticgenesandenhancesdeathreceptorinducedapoptosis AT matthiasbild mir133btargetsantiapoptoticgenesandenhancesdeathreceptorinducedapoptosis AT ulrikejung mir133btargetsantiapoptoticgenesandenhancesdeathreceptorinducedapoptosis AT henrikmuller mir133btargetsantiapoptoticgenesandenhancesdeathreceptorinducedapoptosis AT magnusøarntzen mir133btargetsantiapoptoticgenesandenhancesdeathreceptorinducedapoptosis AT chloepiso mir133btargetsantiapoptoticgenesandenhancesdeathreceptorinducedapoptosis AT carstenstephan mir133btargetsantiapoptoticgenesandenhancesdeathreceptorinducedapoptosis AT berndthiede mir133btargetsantiapoptoticgenesandenhancesdeathreceptorinducedapoptosis AT hansjoachimmollenkopf mir133btargetsantiapoptoticgenesandenhancesdeathreceptorinducedapoptosis AT klausjung mir133btargetsantiapoptoticgenesandenhancesdeathreceptorinducedapoptosis AT stefanhekaufmann mir133btargetsantiapoptoticgenesandenhancesdeathreceptorinducedapoptosis AT jorgschreiber mir133btargetsantiapoptoticgenesandenhancesdeathreceptorinducedapoptosis |
_version_ |
1718423601844060160 |